Hypothalamo‑hypophysial system in rats with autotransplantation of the adrenal cortex

  • Authors:
    • Nae Takizawa
    • Susumu Tanaka
    • Souichi Oe
    • Taro Koike
    • Tadashi Matsuda
    • Hisao Yamada
  • View Affiliations

  • Published online on: March 24, 2017     https://doi.org/10.3892/mmr.2017.6375
  • Pages: 3215-3221
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Patients with bilateral pheochromocytoma often require an adrenalectomy. Autotransplantation of the adrenal cortex is an alternative therapy that could potentially be performed instead of receiving glucocorticoid replacement following adrenalectomy. Adrenal cortex autotransplantation aims to avoid the side effects of long‑term steroid treatment and adrenal insufficiency. Although the function of the hypothalamo‑hypophysial system is critical for patients who have undergone adrenal cortex autotransplantation, the details of that system, with the exception of adrenocorticotropic hormone in the subjects with adrenal autotransplantation, have been overlooked for a long time. To clarify the precise effect of adrenal autotransplantation on the pituitary gland and hypothalamus, the current study examined the gene expression of hormones produced from the hypothalamus and pituitary gland. Bilateral adrenalectomy and adrenal autotransplantation were performed in 8 to 9‑week‑old male rats. The hypothalamus and pituitary tissues were collected at 4 weeks after surgery. Transcriptional regulation of hypothalamic and pituitary hormones was subsequently examined by reverse transcription‑quantitative polymerase chain reaction. Proopiomelanocortin, glycoprotein hormone α polypeptide, and thyroid stimulating hormone β were significantly elevated in the pituitary gland of autotransplanted rats when compared with sham‑operated rats. In addition, there were significant differences in the levels of corticotropin releasing hormone receptor 1 (Crhr1), Crhr2, nuclear receptor subfamily 3 group C member 1 and thyrotropin releasing hormone receptor between the sham‑operated rats and autotransplanted rats in the pituitary gland. In the hypothalamus, corticotropin releasing hormone and urocortin 2 mRNA was significantly upregulated in autotransplanted rats compared with sham‑operated rats. The authors identified significant alterations in the function of not only the hypothalamus‑pituitary‑adrenal axis, but also the adenohypophysis thyrotropes in autotransplanted rats. In the future, it will be important to examine other tissues affected by glucocorticoids following adrenal cortex autotransplantation.

Introduction

The adrenal cortex comprises three layers: Zona glomerulosa, zona fasciculata and zona reticularis. The adrenal cortex mediates the stress response through the production of cortisol. Following bilateral adrenalectomy for the treatment of Cushing's disease, adrenocorticotropic hormone (ACTH)-independent macronodular adrenal hyperplasia and pheochromocytoma, cortisol replacement is necessary for the rest of patients' lives (14). However, patients experience side effects from long-term steroid treatment and are at risk of adrenal insufficiency. Autotransplantation of the adrenal cortex may be an alternative to steroid replacement therapy following bilateral pheochromocytoma, which is a form of catecholamine-producing neuroendocrine tumor (4). To avoid the side effects of cortisol replacement, autotransplantation following bilateral adrenalectomy is required. Successful, autotransplantation may lower the risk of adrenal insufficiency and improve the quality of life for patients.

Upregulation of glucocorticoids and ACTH levels in blood following autotransplantation has been reported in patients with pheochromocytomas following bilateral adrenalectomy (2,5). Notably, there have not been any reports detailing the function of the hypothalamus and pituitary gland following adrenal autotransplantation. Because the autotransplanted adrenal gland does not have the full function of the original adrenal gland (6), dysfunction of the hypothalamus-pituitary axis may occur in patients following autotransplantation. However, the functional alterations in the hypothalamus and pituitary gland following autotransplantation are poorly understood. In the current study, the gene expression in the hypothalamus and pituitary were examined following adrenal autotransplantation using reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis as a pilot study.

Materials and methods

Ethical approval

All experiments were conducted in accordance with the Guidelines (7) and were approved by the Ethics Committee on Animal Experiments of Kansai Medical University (Hirakata, Japan; approval ID: 15-002).

Animal preparation

A total of nine male Wistar rats (age, 8- to 9-weeks-old; weight, 180–240 g) were housed in sound-attenuated light-controlled cages (light on 8:00 a.m. and off 8:00 p.m.; 12 h light-dark cycle; constant environment at 25±1°C and 50±10% relative humidity). Food and water were available ad libitum. Bilateral adrenalectomy was performed on 4 rats following laparotomy under general anesthesia by inhalation of 2% isoflurane (Pfizer Japan Inc., Tokyo, Japan) and 3 l/min oxygen. Resection of the adrenal medulla and midline and horizontal incision was conducted under a stereomicroscope. The 4 chopped-bilateral adrenal capsules and cortex with zona glomerulosa and undifferentiated cell zone (8) were autotransplanted in 4 rats in two abdominal muscle pockets that were formed by a pair of fine scissors (9). Tissue collections were performed at 4 weeks after autotransplantation between 9:00 a.m. and 11:00 a.m. (zeitgeber time (ZT) 1 to ZT3) in all animals. As a control, sham-operations without adrenalectomy were performed in 5 rats, and their tissues were also collected at 4 weeks after surgery. All animals received saline instead of water during the 10 days after surgery, because adrenal-autotransplanted rats cannot survive without saline for 10 days after surgery (10). The animals did not receive any steroid replacement, as rats can survive without steroid replacement following adrenalectomy (11). Rat hypothalamus was dissected coronally from the optic chiasma to the mammillary bodies (−6 mm from the chiasma) using a brain slicer (Zivic Instruments, Pittsburgh, PA, USA). The dorsal limit of the hypothalamus was the roof of the third ventricle, and the lateral limit was the amygdala (12). A total of 32 male Wistar rats (age, 11-12-weeks-old) were housed in same aforementioned conditions and decapitated to identify their diurnal variation in housekeeping genes at 4 h intervals over 24 h from ZT0 to ZT20 of the hypothalamus (n=4 for each ZT) or at ZT2 and ZT14 of the pituitary (n=4 for each ZT).

RT-qPCR

Total RNA was isolated from each individual hypothalamus and whole pituitary gland using Sepasol-RNA I Super G reagent (Nacalai Tesque, Inc., Kyoto, Japan). Single-stranded cDNA was synthesized using the PrimeScript RT reagent kit with gDNA Eraser (Takara Bio, Inc., Otsu, Japan). The expression level of each mRNA was determined by RT-qPCR with an ABI 7300 system (Applied Biosystems; Thermo Fisher Scientific, Inc., Waltham, MA, USA) using the THUNDERBIRD qPCR mix (Toyobo Co., Ltd., Osaka, Japan) and gene-specific primers (Table I). PCR products were amplified using the following thermocycling conditions: 1 cycle, 1 min, 95°C; 40 cycles, 10 sec, 95°C, 60 sec, 60°C.

Table I.

Primers for reverse transcription-quantitative polymerase chain reaction.

Table I.

Primers for reverse transcription-quantitative polymerase chain reaction.

Gene symbolAccession numberForward primer (5′-3′)Reverse primer (5′-3′)
Gh1NM_001034848.2 tgtttgccaatgctgtgctc tgaatggaatagcgctgtcc
PrlNM_012629.1 tttggtgcactcctggaatg agccgcttgttttgttcctc
TshbNM_013116.2 ttccgtgcttttcgctcttg agatggtggtgttgatggtcag
FshbNM_001007597.1 tgaagtcgatccagctttgc atgcagaaacggcactcttc
LhbNM_012858.2 ttctgatgcccacccactaac aagcctttattgggagggatgg
CgaNM_053918.2 atcagtgtatgggctgttgc atgatttggccacacagcac
PomcNM_139326.2 ttcatgacctccgagaagagc tgtgcgcgttcttgatgatg
CrhNM_031019.1 gaatacttcctccgcctggg ggaaaaagttagccgcagcc
Crhr1NM_030999.3 ttctgaacagtgaggtccgc aggtggggatggacatagct
Crhr2NM_022714.1 ccgaatcgccctcatcatca ttcgtggtcgatgagttgca
Nr3c1 (GR)NM_012576.2 aaatgggcaaaggcgatacc agcaaagcagagcaggtttc
TrhNM_013046.3 aaaagggcattgggtcatcc acttgtgggctttgcttcac
TrhrNM_013047.3 ccatcaacccggtgatttac aaagcggtctgactccttga
Ucn2NM_133385 atgtttctgaacccctcacg gacacagctaggcacgacaa
Hprt1NM_012583.2 cctgttgatgtggccagtaaag atcaaaagggacgcagcaac
Rplp2NM_001030021.1 attgaggatgtcatcgctcagg tctttcttctcctctgctgcag
YwhazNM_013011.3 ttcgcagccagaaagcaaag ttgtcatcaccagcagcaac

[i] Gh1, growth hormone 1; Prl, prolactin; Tshb, thyroid stimulating hormone β; Fshb, follicle stimulating hormone β polypeptide; Lhb, luteinizing hormone β polypeptide; Cga, glycoprotein hormones α polypeptide; Pomc, proopiomelanocortin; Crh, corticotropin releasing hormone; Crhr1, corticotropin releasing hormone receptor 1; Crhr2, corticotropin releasing hormone receptor 2; Nr3c1, nuclear receptor subfamily 3 group C member 1; Trh, thyrotropin releasing hormone; Trhr, thyrotropin releasing hormone receptor; Ucn2, urocortin 2; Hprt1, hypoxanthine phosphoribosyltransferase 1; Rplp2, ribosomal protein large P2; Ywhaz, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein-z.

The housekeeping gene with minimum diurnal variation was identified using a Rat Housekeeping Gene Primer set (Takara Bio, Inc.) in the hypothalamus at 4 h intervals over a 24 h period. Hypoxanthine phosphoribosyltransferase-1 (Hprt1), ribosomal protein large P2 (Rplp2) and tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein-z (Ywhaz) primers were newly synthesized for the relative quantification of the gene expression in the hypothalamus and pituitary (Table I). Subsequently, the relative level of target gene expression was evaluated using the 2−ΔΔCq method (13) with Hprt1 as an internal control.

Statistical analysis

Distributions [mean ± standard deviation (SD)] of relative gene expressions were compared using unpaired Student's t-test in Microsoft Excel software. P<0.05 was considered to indicate a statistically significant difference.

Results

Pituitary hormones and hypothalamic releasing hormones possess diurnal variation. In addition, certain housekeeping genes may also have this variation. Therefore, to avoid false-positive results caused by the sampling time and to increase the stringency of relative hormone mRNA measurements, the housekeeping genes with minimum diurnal variation were examined. The relative quantity of housekeeping gene expression was evaluated using the 2−ΔΔCq method with ATP synthase H+ transporting mitochondrial Fo complex subunit B1 used as the reference gene. The Hprt1 gene had minimal variation over a 24 h period in the rat hypothalamus (mean ± SD; 1.08±0.05, coefficient of variation; 4.55%; Fig. 1; Table II). There was no significant difference in the relative expression of Hprt1 in pituitary tissue between ZT2 (1.16±0.15) and ZT14 (1.18±0.20; P=0.865). Hprt1 had minimal variation, when compared with Rplp2 and Ywhaz, which were the housekeeping genes with the second and third lowest diurnal variation in the hypothalamus. In addition, there was no significant difference of Rplp2 in the pituitary gland between ZT2 (1.37±0.26) and ZT14 (1.17±0.13; P=0.106) but, notably, there was a significant difference in the pituitary gland of Ywhaz between ZT2 (1.61±0.13) and ZT14 (1.09±0.09; P<0.001).

Table II.

Diurnal variations of housekeeping genes in the rat hypothalamus.

Table II.

Diurnal variations of housekeeping genes in the rat hypothalamus.

Gene symbolMean expressionaStandard deviationCoefficient of variation (%)
Hprt11.0800.0494.545
Rplp21.0890.0555.045
Ywhaz1.0750.0645.940
Gusb1.1120.1029.154
Tbp1.1590.1079.250
Ppia1.1910.13511.356
Actb1.2050.14411.965
B2m1.2590.14411.459
Rps181.1800.16514.007
Pgk11.2290.20116.313
Gapdh1.2590.23918.953

a Mean expression across all time points (ZT0, ZT4, ZT8, ZT12, ZT16 and ZT20) relative to ATP synthase H+ transporting mitochondrial Fo complex subunit B1. Hprt1, hypoxanthine phosphoribosyltransferase 1; Rplp2, ribosomal protein large P2; Ywhaz, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein-z; Gusb, glucuronidase-β; Tbp, TATA box binding protein; Ppia, peptidylprolyl isomerase A; Actb, β-actin; B2m, β-2 microglobulin; Rps18, ribosomal protein S18; Pgk1, phosphoglycerate kinase 1; Gapdh, glyceraldehyde-3-phosphate dehydrogenase.

Subsequently, Hprt1 was used as the internal control. Proopiomelanocortin (Pomc; 64.28±11.39 vs. 22.63±3.39; P<0.005), glycoprotein hormones α polypeptide (Cga; 1.69±0.14 vs. 1.16±0.17; P<0.01) and thyroid stimulating hormone β (Tshb; 9.60±3.61 vs. 3.90±1.02; P<0.05) were demonstrated to be significantly elevated in the pituitary gland of autotransplanted rats, when compared with sham-operated rats (Fig. 2). There was no significant difference in prolactin (Prl; 1.83±0.46 vs. 1.47±0.64), growth hormone-1 (Gh1; 2.06±1.53 vs. 1.89±0.77), luteinizing hormone β polypeptide (1.32±0.22 vs. 1.51±0.39), follicle stimulating hormone β polypeptide (1.59±0.51 vs. 1.66±0.45) and urocortin-2 (Ucn2; 14.97±11.99 vs. 11.80±5.74) in the pituitary gland between sham-operated rats and autotransplanted rats (Figs. 2 and 3). There were significant differences in expression of corticotropin releasing hormone receptor 1 (Crhr1; 3.03±0.68 vs. 6.61±1.78; P<0.01), Crhr2 (9.55±1.90 vs. 102.96±61.14; P<0.05), nuclear receptor subfamily 3 group C member 1 (Nr3c1; 7.86±7.81 vs. 63.35±34.86; P<0.05) and thyrotropin releasing hormone receptor (Trhr; 2.55±0.24 vs. 1.17±0.24; P<0.005) in the pituitary gland between sham-operated rats and autotransplanted rats (Fig. 3). In the hypothalamus, corticotropin releasing hormone (Crh; 1.65±0.55 vs. 2.45±0.31; P<0.05) and Ucn2 (150.03±127.97 vs. 611.46±252.98; P<0.01) were significantly upregulated in autotransplanted rats compared with sham-operated rats (Fig. 3). There were no significant differences in levels of Pomc (1.46±0.32 vs. 1.82±0.53), Trh (23.67±6.78 vs. 26.29±10.55), Crhr1 (1.53±0.99 vs. 1.60±0.65), Crhr2 (7.27±4.31 vs. 4.51±3.31) and Nr3c1 (35.53±15.35 vs. 46.11±14.90) in the hypothalamus between sham-operated rats and autotransplanted rats (Fig. 3). In both the pituitary gland and the hypothalamus, there was no difference in Rplp2 (1.48±0.52 vs. 1.46±0.15 in the hypothalamus; and 1.51±0.38 vs. 1.70±0.28 in the pituitary gland) and Ywhaz (2.34±0.67 vs. 2.70±0.21 in the hypothalamus; and 3.06±1.43 vs. 2.60±1.58 in the pituitary gland) between sham-operated rats and autotransplanted rats (Fig. 3).

Discussion

Autotransplantation following bilateral adrenalectomy helps to avoid steroid replacement therapy in postoperative pheochromocytoma patients. To the best of our knowledge, there are no studies regarding the hypothalamo-hypophysial system without ACTH in subjects following autotransplantation. To clarify the precise effect of adrenal autotransplantation on the pituitary and hypothalamic function, the authors examined whether there were significant differences in the hypothalamus-pituitary-adrenal axis, and other hormonal systems following adrenal autotransplantation. In the current study, there were increased levels of Pomc, Cga, Tshb, Crhr1, Crhr2 and Nr3c1 transcripts in the pituitary gland and Crh and Ucn2 transcripts in the hypothalamus of autotransplanted rats compared with sham rats. In addition, the results demonstrated decreased levels of Trhr in the pituitary gland of autotransplanted rats compared with sham rats.

The hypothalamus neuropeptide, CRH is secreted from the paraventricular nucleus during stress responses. CRH activates the hypothalamic-pituitary-adrenal axis, modulating stress-induced ACTH secretion from the pars distalis. ACTH is proteolytically synthesized from the large precursor protein, POMC, by the anterior pituitary corticotrophs. The increase in blood ACTH level results in the adrenocortical release of cortisol and aldosterone (14,15). CRH itself is inhibited by glucocorticoids, which acts as a classical negative feedback loop. Therefore, the elevations of Pomc, Crhr1, Crhr2, Nr3c1 and Crh transcripts in the present study are in line with the decrease in the negative feedback of glucocorticoids, due to the hypofunctioning autotransplanted adrenal cortex (6). The CRHR1 mediates the effects of CRH on the hypothalamus-pituitary-adrenal axis (16,17). The stress-inducible ACTH secretion from the anterior pituitary corticotrophs is impaired in Crhr1−/− mice (18,19). Hypersensitivity of the hypothalamus-pituitary-adrenal axis against stress conditions has been demonstrated in Crhr2 null mice (20,21). One member of the CRH family, the UCN2 protein, selectively binds to CRHR2 (22) and an elevation of Ucn2 mRNA was identified in the hypothalamus of the autotransplanted rats in the current study. Therefore, Pomc transcription in autotransplanted rats may be regulated by hypothalamic CRH and UCN2 in a coordinated manner.

In addition, Cga and Tshb expression are upregulated in the pituitary gland of autotransplanted rats. Glucocorticoids inhibit Cga expression mediated by the glucocorticoid responsive element (GRE) to the 5′-flanking region containing the cAMP-response element with a tissue-specific element of the Cga gene (2325). Basal and thyrotropin-releasing hormone (TRH)-stimulated total TSH, CGA and TSHB secretion were decreased following dexamethasone administration in patients with hypothyroiditis (26). As chronic insufficiency of adrenocortical function due to autotransplantation induces low blood levels of glucocorticoids, it is speculated that subclinical hyperthyroiditis was induced in adrenal autotransplanted animals.

Tshb expression was upregulated in the pituitary gland of autotransplanted rats, however there is no report on the direct effect of glucocorticoid on Tshb transcription. The GRE in the upstream region of the Tshb gene has not yet been identified (27). By contrast, there is a GRE in the 5′-flanking region of the Trh gene. Trh transcription is directly regulated by glucocorticoids (28,29), therefore it was suggested that the increase in Trh expression and subsequent Tshb elevation had occurred in the autotransplanted rats by the mechanism reported by Walter et al (30). Unexpectedly, there was no significant change in Trh expression in the current study. Prepro-TRH is synthesized in the neuronal cell bodies of various brain regions (31). Although several hypothalamic nuclei synthesize TRH, the TRH neurons regulating pituitary TSH release are localized exclusively to the paraventricular nucleus (32,33). In the present study, the whole hypothalamus was used to determine the expression level of Trh, therefore changes in Trh expression caused by autotransplantation in the paraventricular nucleus could not be detected in the present samples. Subsequently, the downregulation of Trhr expression was demonstrated to occur in the pituitary gland of the autotransplanted rats. The direct transcriptional enhancement of Trhr induced by glucocorticoids via GRE has been well described (3436). These results suggested that Tshb expression in the pituitary gland of autotransplanted rats was regulated by a different pathway from the TRH-TRHR system or direct glucocorticoid effect.

In conclusion, the results identified an elevation in gene expression of the hypothalamus-pituitary-adrenal axis and adenohypophysis thyrotrophs in autotransplanted rats, suggesting that a small amount of cortisol replacement is required even following autotransplantion. Future studies will examine gene expression in other tissues following adrenal autotransplantation.

Acknowledgements

The present study was supported by the Japan Society for the Promotion of Science KAKENHI fund (grant nos. 25280052 and 15K08224 to Dr Susumu Tanaka), the research grant from Kansai Medical University to Dr Nae Takizawa, and MEXT-Supported Program for the Strategic Research Foundation at Private Universities (grant nos. S1101034 and S1201038 to Dr Hisao Yamada). The authors would like to thank Dr Kiyoshi Kurokawa (Osaka International University, Hirakata, Japan) and Dr Yukie Hirahara-Wada (Kansai Medical University, Hirakata, Japan) for their helpful comments.

Glossary

Abbreviations

Abbreviations:

ACTH

adrenocorticotropic hormone

Atp5f1

ATP synthase H+ transporting mitochondrial Fo complex subunit B1

Cga

glycoprotein hormones α polypeptide

Crh

corticotropin releasing hormone

Crhr1

corticotropin releasing hormone receptor 1

Crhr2

corticotropin releasing hormone receptor 2

Fshb

follicle stimulating hormone β polypeptide

Gh1

growth hormone 1

GRE

glucocorticoid responsive element

Hprt1

hypoxanthine phosphoribosyltransferase 1

Lhb

luteinizing hormone β polypeptide

Nr3c1

nuclear receptor subfamily 3 group C member 1

Prl

prolactin

Rplp2

ribosomal protein large P2

Trh

thyrotropin releasing hormone

Trhr

thyrotropin releasing hormone receptor

Tshb

thyroid stimulating hormone β

Ucn2

urocortin 2

Ywhaz

tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein z

Pomc

proopiomelanocortin

References

1 

Erdogan G, Kologlu S, Kamel N, Baskal N, Cesur V and Eraslan S: Adrenal autotransplantation after total adrenalectomy: Delayed determined function. Endocr J. 41:45–48. 1994. View Article : Google Scholar : PubMed/NCBI

2 

Lucon AM, Mendonça BB, Domenice S, Chambô JL, Wajchemberg BL and Arap S: Adrenal autografts following bilateral adrenalectomy. J Urol. 149:977–979. 1993.PubMed/NCBI

3 

Kubo N, Onoda N, Ishikawa T, Ogawa Y, Takashima T, Yamashita Y, Tahara H, Inaba M and Hirakawa K: Simultaneous bilateral laparoscopic adrenalectomy for adrenocorticotropic hormone-independent macronodular adrenal hyerplasia: Report of a case. Surg Today. 36:642–646. 2006. View Article : Google Scholar : PubMed/NCBI

4 

Inabnet WB, Caragliano P and Pertsemlidis D: Pheochromocytoma: Inherited associations, bilaterality and cortex preservation. Surgery. 128:1007–1012. 2000. View Article : Google Scholar : PubMed/NCBI

5 

Okamoto T, Obara T, Ito Y, Yamashita T, Kanbe M, Iihara M, Hirose K and Yamazaki K: Bilateral adrenalectomy with autotransplantation of adrenocortical tissue or unilateral adrenalectomy: Treatment options for pheochromocytomas in multiple endocrine neoplasia type 2A. Endocr J. 43:169–175. 1996. View Article : Google Scholar : PubMed/NCBI

6 

Taniguchi A, Tajima T, Nonomura K, Shinohara N, Mikami A and Koyanagi T: Expression of vascular endothelial growth factor and its receptors Flk-1 and Flt-1 during the regeneration of autotransplanted adrenal cortex in the adrenalectomized rat. J Urol. 171:2445–2449. 2004. View Article : Google Scholar : PubMed/NCBI

7 

National Research Council of The National Academies: Guide for the care and use of laboratory animals. 8th. The National Academies Press (US); Washington, DC: 2011

8 

Mitani F: Functional zonation of the rat adrenal cortex: The development and maintenance. Proc Jpn Acad Ser B Phys Biol Sci. 90:163–183. 2014. View Article : Google Scholar : PubMed/NCBI

9 

Belloni AS, Neri G, Musajo FG, Andreis PG, Boscaro M, D'Agostino D, Rebuffat P, Boshier DP, Gottardo G, Mazzocchi G, et al: Investigations on the morphology and function of adrenocortical tissue regenerated from gland capsular fragments autotransplanted in the musculus gracilis of the rat. Endocrinology. 126:3251–3262. 1990. View Article : Google Scholar : PubMed/NCBI

10 

Hirose J, Masuda H, Ushiyama T, Ohtawara Y, Ohta N, Suzuki K, Tajima A and Aso Y: Histological and encrinological observations on the regeneration of the autotransplanted adrenal gland in the rat. Nihon Hinyokika Gakkai Zasshi. 79:666–672. 1988.(In Japanese). PubMed/NCBI

11 

Srougi M and Gittes RF: Adrenal autotransplantation. Urol Surv. 28:41–48. 1978.PubMed/NCBI

12 

Terao A, Wisor JP, Peyron C, Apte-Deshpande A, Wurts SW, Edgar DM and Kilduff TS: Gene expression in the rat brain during sleep deprivation and recovery sleep: An affymetrix genechip study. Neuroscience. 137:593–605. 2006. View Article : Google Scholar : PubMed/NCBI

13 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

14 

Owens MJ and Nemeroff CB: Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev. 43:425–473. 1991.PubMed/NCBI

15 

Steckler T and Holsboer F: Corticotropin-releasing hormone receptor subtypes and emotion. Biol Psychiatry. 46:1480–1508. 1999. View Article : Google Scholar : PubMed/NCBI

16 

Skutella T, Criswell H, Moy S, Probst JC, Breese GR, Jirikowski GF and Holsboer F: Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide induces anxiolytic effects in rat. Neuroreport. 5:2181–2185. 1994. View Article : Google Scholar : PubMed/NCBI

17 

Skutella T, Montkowski A, Stöhr T, Probst JC, Landgraf R, Holsboer F and Jirikowski GF: Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide treatment attenuates social defeat-induced anxiety in rats. Cell Mol Neu. 14:579–588. 1994. View Article : Google Scholar

18 

Timpl P, Spanagel R, Sillaber I, Kresse A, Reul JM, Stalla GK, Blanquet V, Steckler T, Holsboer F and Wurst W: Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat Genet. 19:162–166. 1998. View Article : Google Scholar : PubMed/NCBI

19 

Smith GW, Aubry JM, Dellu F, Contarino A, Bilezikjian LM, Gold LH, Chen R, Marchuk Y, Hauser C, Bentley CA, et al: Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response and, aberrant neuroendocrine development. Neuron. 20:1093–1102. 1998. View Article : Google Scholar : PubMed/NCBI

20 

Bale TL, Contarino A, Smith GW, Chan R, Gold LH, Sawchenko PE, Koob GF, Vale WW and Lee KF: Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet. 24:410–414. 2000. View Article : Google Scholar : PubMed/NCBI

21 

Coste SC, Kesterson RA, Heldwein KA, Stevens SL, Heard AD, Hollis JH, Murray SE, Hill JK, Pantely GA, Hohimer AR, et al: Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat Genet. 24:403–419. 2000. View Article : Google Scholar : PubMed/NCBI

22 

Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, Hogenesch JB, Gulyas J, Rivier J, Vale WW and Sawchenko PE: Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci USA. 98:2843–2848. 2001. View Article : Google Scholar : PubMed/NCBI

23 

Akerblom IE, Slater EP, Beato M, Baxter JD and Mellon PL: Negative regulation by glucocorticoids through interference with a cAMP responsive enhancer. Science. 241:350–353. 1988. View Article : Google Scholar : PubMed/NCBI

24 

Gurr JA and Kourides IA: Regulation of the transfected human glycoprotein hormone alpha-subunit gene by dexamethasone and thyroid hormone. DNA. 8:473–480. 1989. View Article : Google Scholar : PubMed/NCBI

25 

Chatterjee VK, Madison LD, Mayo S and Jameson JL: Repression of the human glycoprotein hormone alpha-subunit gene by glucocorticoids: Evidence for receptor interactions with limiting transcriptional activators. Mol Endocrinol. 5:100–110. 1991. View Article : Google Scholar : PubMed/NCBI

26 

Kourides IA, Weintraub BD, Re RN, Ridgway EC and Maloof F: Thyroid hormone, oestrogen and glucocorticoid effects on two different pituitary glycoprotein hormone alpha subunit pools. Clin Endocrinol (Oxf). 9:535–542. 1978. View Article : Google Scholar : PubMed/NCBI

27 

Reddy TE, Pauli F, Sprouse RO, Neff NF, Newberry KM, Garabedian MJ and Myers RM: Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation. Genome Res. 19:2163–2171. 2009. View Article : Google Scholar : PubMed/NCBI

28 

Cote-Vélez A, Pérez-Martínez L, Charli JL and Joseph-Bravo P: The PKC and ERK/MAPK pathways regulate glucocorticoid action on TRH transcription. Neurochem Res. 33:1582–1591. 2008. View Article : Google Scholar : PubMed/NCBI

29 

Díaz-Gallardo MY, Cote-Vélez A, Charli JL and Joseph-Bravo P: A rapid interference between glucocorticoids and cAMP-activated signalling in hypothalamic neurones prevents binding of phosphorylated cAMP response element binding protein and glucocorticoid receptor at the CRE-Like and composite GRE sites of thyrotrophin-releasing hormone gene promoter. J Neuroendocrinol. 22:282–293. 2010. View Article : Google Scholar : PubMed/NCBI

30 

Walter KN, Corwin EJ, Ulbrecht J, Demers LM, Bennett JM, Whetzel CA and Klein LC: Elevated thyroid stimulating hormone is associated with elevated cortisol in healthy young men and women. Thyroid Res. 5:132012. View Article : Google Scholar : PubMed/NCBI

31 

Joseph-Bravo P, Jaimes-Hoy L and Charli JL: Regulation of TRH neurons and energy homeostasis-related signals under stress. J Endocrinol. 224:R139–R159. 2015. View Article : Google Scholar : PubMed/NCBI

32 

Fekete C and Lechan RM: Central regulation of hypothalamic-pituitary-thyroid axis under physiological and pathophysiological conditions. Endocr Rev. 35:159–194. 2014. View Article : Google Scholar : PubMed/NCBI

33 

Fliers E, Kalsbeek A and Boelen A: Beyond the fixed setpoint of the hypothalamus-pituitary-thyroid axis. Eur J Endocrinol. 171:R197–R208. 2014. View Article : Google Scholar : PubMed/NCBI

34 

Høvring PI, Matre V, Fjeldheim AK, Loseth OP and Gautvik KM: Transcription of the human thyrotropin-releasing hormone receptor gene-analysis of basal promoter elements and glucocorticoid response elements. Biochem Biophys Res Commun. 257:829–834. 1999. View Article : Google Scholar : PubMed/NCBI

35 

Yang J and Tashjian AH Jr: Regulation of endogenous thyrotropin-releasing hormone receptor messenger RNA in GH4C1 cells: Roles of protein and RNA synthesis. Mol Endocrinol. 7:1144–1150. 1993. View Article : Google Scholar : PubMed/NCBI

36 

Yang J and Tashjian AH Jr: Transcriptional regulation by dexamethasone of endogenous thyrotropin-releasing hormone receptor messenger ribonucleic acid in rat pituitary GH4C1 cells. Endocrinology. 133:487–490. 1993. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

May-2017
Volume 15 Issue 5

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Takizawa N, Tanaka S, Oe S, Koike T, Matsuda T and Yamada H: Hypothalamo‑hypophysial system in rats with autotransplantation of the adrenal cortex. Mol Med Rep 15: 3215-3221, 2017
APA
Takizawa, N., Tanaka, S., Oe, S., Koike, T., Matsuda, T., & Yamada, H. (2017). Hypothalamo‑hypophysial system in rats with autotransplantation of the adrenal cortex. Molecular Medicine Reports, 15, 3215-3221. https://doi.org/10.3892/mmr.2017.6375
MLA
Takizawa, N., Tanaka, S., Oe, S., Koike, T., Matsuda, T., Yamada, H."Hypothalamo‑hypophysial system in rats with autotransplantation of the adrenal cortex". Molecular Medicine Reports 15.5 (2017): 3215-3221.
Chicago
Takizawa, N., Tanaka, S., Oe, S., Koike, T., Matsuda, T., Yamada, H."Hypothalamo‑hypophysial system in rats with autotransplantation of the adrenal cortex". Molecular Medicine Reports 15, no. 5 (2017): 3215-3221. https://doi.org/10.3892/mmr.2017.6375